Figure 1.
Kaplan–Meier curves of progression-free survival and overall survival.
Kaplan–Meier curves with respective 95% CIs of progression-free survival (A and C) and overall survival (B and D) in the overall population and in the subpopulation with time-to-relapse ≤6 months, respectively.
aHR, adjusted hazard ratio; CI, confidence interval; HR, hazard ratio; P + T, pertuzumab + trastuzumab.